FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs
FDA approves first generic drug under Competitive Generic Therapy (CGT) designation for products with inadequate generic competition
FDA approves first generic drug under Competitive Generic Therapy (CGT) designation for products with inadequate generic competition